Actidogesic Df Tablet
NDC Package 63102-403-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Actidogesic Df (acetaminophen, dexbrompheniramine maleate) tablets is adults and children12 years of age and olderTake 2 caplets every 4 to 6 hours as needed,do not exceed 8 caplets in 24 hours, or asdirected by a doctor, do not use for more than10 days unless directed by a doctor.Children under 12  years of age Do not use. This formulation utilizes a tablet delivery system. Marketed by Actipharma, Llc, this product is identified by NDC 63102-403 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
63102-403-10
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
63102-403
11-Digit Billing Format
63102040310
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1798453 - acetaminophen 500 MG / dexbrompheniramine maleate 1 MG Oral Tablet
  • RxCUI: 1798453 - APAP 500 MG / Dexbrompheniramine maleate 1 MG Oral Tablet

Clinical Specifications

Proprietary Name
Actidogesic Df
Non-Proprietary Name
Acetaminophen, Dexbrompheniramine Maleate
Substance Name
Acetaminophen; Dexbrompheniramine Maleate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Adults and children12 years of age and olderTake 2 caplets every 4 to 6 hours as needed,do not exceed 8 caplets in 24 hours, or asdirected by a doctor, do not use for more than10 days unless directed by a doctor.Children under 12  years of age Do not use.

Regulatory & Marketing

Labeler Name
Actipharma, Llc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-10-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63102-403-10 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Actidogesic Df, a human over the counter drug labeled by Actipharma, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains acetaminophen; dexbrompheniramine maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actipharma, Llc on July 10, 2020. The current certification is valid through December 31, 2026.

How is this Actipharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63102040310. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63102-403-10
11-Digit CMS (5-4-2)
63102-0403-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.